Stock Quote

Solvay SA (SOLB.BR) (Brussels Stock Exchange)
As of  27 Nov 2009
71.50EUR
Price Change
+1.11
Percent Change
+1.58%
 
€71.50
27 Nov 2009
+1.58%
€70.39
€69.37
172,870
€71.73
€69.20
€78.00
€41.29
0.96
166,946

Research Another Stock: Symbol Look-up
DIARY - Belgium to February 28, 2010
Friday, 27 Nov 2009 12:00am EST 
DIARY - Belgium to February 28, 2010
Thursday, 26 Nov 2009 12:00am EST 
DIARY - Belgium to February 28, 2010
Tuesday, 24 Nov 2009 12:00am EST 
UPDATE 3-Solvay Q3 profit tops estimates, markets tough
Thursday, 29 Oct 2009 05:05am EDT 
STOCKS NEWS EUROPE-Index futures point to lower open
Thursday, 29 Oct 2009 03:09am EDT 
 
Name Current Position Compensation
Michielsen, Alois Chairman of the Board 705,094
Jourquin, Christian Chairman of the Executive Committee, Chief Executive Officer, Executive Director 57,500
Solvay, Denis Vice Chairman of the Board, Independent Director 60,000

Profile

Solvay SA is a chemicals and pharmaceuticals company. The Company operates in three sectors: pharmaceuticals, chemicals and plastics. The pharmaceuticals sector is engaged in the therapeutic fields of cardiometabolic, neuroscience, flu vaccines, pancreatic enzymes and gastroenterology. The chemicals... Full Description

Company Address

Solvay SA
Rue de Prince Albert 33
Bruxelles     1050
P: +322.5096111
F: +322.5096617

Analyst Research

  SOLB.BR Industry
P/E(TTM) 78.92 1.07
P/S(TTM) 0.90 0.07
ROI(TTM) 1.03 0.30
ROE(TTM) 1.61 0.50
Consensus Recommendation Outperform
EPS Est. (Current Period) --
EPS Est. (Current Year) 5.30
Total Revenue $1,484.00M
Net Income $26.00M
EPS $0.17